Bristol-Myers Squibb Co. (BMY) Shares Tick Up after Upgrade at Zacks Investment Research

Bristol-Myers Squibb Co. (NYSE: BMY) shares rose in value Wednesday Dec 14 with lighter trade volume than normal after a number of analysts weighed in on the investing value of the stock with a upgraded rating.

Meanwhile, U.S. equities traded mostly lower on Wednesday as investors awaited the Federal Reserve’s latest decision regarding monetary policy.

The Dow Jones industrial average traded 35 points lower, with Goldman Sachs contributing the most losses. The S&P 500 traded 0.1 percent lower, with financials leading decliners. The Nasdaq composite, meanwhile, held flat.

Analysts at Zacks Investment Research upgraded shares of Bristol-Myers Squibb Co. (NYSE: BMY) from Hold to Buy today. The company currently has a rating of Buy on the shares. A number of other analysts have commented on the stock in recent days, and Bristol-Myers Squibb Co. has secured a consensus one-year price target of $62.11, higher than the opening price of $57.30, a difference of 10.66 percent. Bristol-Myers Squibb Co. stock has a 52-week high of $77.12. Typically, after analysts issue an upgrade report on a stock, they will later issue other revisions, such as a price target change.

Shares of Bristol-Myers Squibb Co. (NYSE: BMY) opened at $57.30 on Tuesday and has traded in a range between, $57.27 and $58.33, and last traded at $58.26, a jump of $1.09 or 1.91% compared to the previous closing price.

Bristol-Myers Squibb Co. (NYSE: BMY) currently has a market cap of 97.37B.

Bristol-Myers Squibb Co. (NYSE: BMY) Average Daily Trading Volume

The stock’s average daily volume is 12,457,400 shares out of a total float 1,668,789,000 and some 1,440,877 shares crossed the trading desk yesterday, lower than normal. Investors often use increases in trading volume to identify heavy volume aggregation or dissemination by institutional investors, so trading volume is likely to increase in the next few days.

However, just a day of significant buy side trading is not enough to determine a trend. As such, market traders will continue to look for institutional sponsorship as an indicator that financial institutions are moving forward.

Institutional sponsorship just refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These professional investors have substantial teams of analysts researching thousands of stocks, so it is good confirmation to see them taking a postion in a stock you’re researching.

Bristol-Myers Squibb Co. (NYSE: BMY) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

Traders can make educated trades when they track the trading habits of professional investors.

Trades for Bristol-Myers Squibb Co. (NYSE: BMY) have ranged from $49.03 – 77.12, and the stock now has a 50-day MA of $54.69 and 200-day MA of $61.68. Today’s last price is 24.46%% below the 52 week high of $77.12.

Indeed, earnings growth is among the most critical things to look at in regards to stock investing and, accordingly, investors look for companies that have raised their earnings at least 25% or more for 3 consecutive years.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *